Zydus Lifesciences Limited said on Wednesday, March 18, that it has entered into a Licensing and Supply Agreement with Torrent Pharmaceuticals Limited to co-market...
Indian drugmakers have launched semaglutide injections after the patent on the GLP-1 molecule expired in India on March 20, opening the market to lower-priced...
Zydus Lifesciences has launched two artificial intelligence-powered continuous glucose monitoring (CGM) devices — Diasens and GlucoLive — expanding its companion diagnostics portfolio as demand...